4-hydroxybutyric acid has been researched along with vigabatrin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Al-Essa, MA; Bakheet, SM; Ozand, PT; Patay, ZJ; Powe, JE | 1 |
| Ergezinger, K; Frauendienst-Egger, G; Gibson, KM; Jeschke, R; Korall, H; Schuster, VH | 1 |
| Boenzi, S; Carducci, C; Deodato, F; Di Sabato, ML; Dionisi-Vici, C; Leuzzi, V; Liberanome, C; Malaspina, P; Rizzo, C | 1 |
1 review(s) available for 4-hydroxybutyric acid and vigabatrin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for 4-hydroxybutyric acid and vigabatrin
| Article | Year |
|---|---|
Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI of the brain and biochemical observations in a patient with 4-hydroxybutyric aciduria; a progressive neurometabolic disease.
Topics: Brain; Child, Preschool; Dextromethorphan; Fluorodeoxyglucose F18; Humans; Hydroxybutyrates; Magnetic Resonance Imaging; Male; Metabolism, Inborn Errors; Saudi Arabia; Tomography, Emission-Computed; Vigabatrin | 2000 |
Monitoring of 4-hydroxybutyric acid levels in body fluids during vigabatrin treatment in succinic semialdehyde dehydrogenase deficiency.
Topics: Aldehyde Oxidoreductases; Child; Developmental Disabilities; Enzyme Inhibitors; Female; Humans; Hydroxybutyrates; Metabolism, Inborn Errors; Succinate-Semialdehyde Dehydrogenase; Treatment Outcome; Vigabatrin | 2003 |
Vigabatrin improves paroxysmal dystonia in succinic semialdehyde dehydrogenase deficiency.
Topics: Adolescent; Brain; Brain Diseases, Metabolic; Dystonic Disorders; Epilepsy; Extremities; GABA Agents; gamma-Aminobutyric Acid; Gene Expression Regulation, Enzymologic; Humans; Hydroxybutyrates; Intellectual Disability; Italy; Male; Muscle, Skeletal; Mutation, Missense; Succinate-Semialdehyde Dehydrogenase; Treatment Outcome; Vigabatrin | 2007 |